Hepatitis B Virus‐Hepatitis D Virus mother‐to‐child co‐transmission: A retrospective study in a developed country
Pierre Sellier(Inserm), Jean‐François Bergmann(Northern General Hospital), Ségolène Brichler(Inserm), V. Delcey(Hôpital Fernand-Widal), Sarah Maylin(Inserm), D Chopin(Hôpital Fernand-Widal), Guy G. Simoneau(Hôpital Fernand-Widal), Manuela Pogliaghi(Hôpital Fernand-Widal), Béatrice Berçot(Hôpital Fernand-Widal), Emmanuel Gordien(Inserm), Amanda Lopes(Hôpital Fernand-Widal), John Evans(Hôpital Fernand-Widal), Anne‐Lise Munier(Hôpital Fernand-Widal), François Simon
Cited by 50
Related Papers
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a <i>Deltavirus</i> Genus of at Least Seven Major Clades
|Journal of Virology|2004|221
Eighth Major Clade for Hepatitis Delta Virus
|Emerging infectious diseases|2006|206
Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein
|Journal of Virology|2001|185